ISMP has identified the top three medication errors and hazards that were recurring themes in the acute care newsletter in 2023 and can be avoided or minimized with system and/or practice changes. See this week’s featured newsletter article for prevention strategies: www.ismp.org/node/128186
MSOS News
Increased demand and shortages of GLP-1 receptor agonists to aid in weight loss has led to reported errors with compounded versions of these drugs. For safe practice recommendations: www.ismp.org/node/126800
Sign up now for the next MSOS Member Briefing webinar scheduled to be held on Thursday, March 28, 2024 from 1:00-2:00 PM ET. Register Now:
Short medication safety-related presentations for this webinar will include: https://ecri.zoom.us/webinar/register/WN_p-ku-A2AS-yhIcvIRUoRug
• What Did You Mean? Instructions on Prescriptions
Mariam Gawdat, PharmD, MS
FDA/ISMP Safe Medication Management Fellow
ISMP
• Simulation Medications, the Risk is “Real”
Mara Weber, PharmD, BSRT
Medication Safety Pharmacist
OhioHealth- Doctor’s Hospital
• Federal Funding Opportunities for Medication Safety Research
Farzana Samad, PharmD, FISMP
Health Science Administrator
Agency for Healthcare Research and Quality
• ISMP Update
Rita K. Jew, PharmD, MBA, BCPPS, FASHP
President, ISMP
Patient Safety Awareness Week is a good time to assess how your organization is applying ISMP’s 2024-2025 Targeted Medication Safety Best Practices for Hospitals. Please participate in our online survey to establish a baseline measurement of current level of implementation—deadline is April 19, 2024: https://www.ismp.org/guidelines/best-practices-hospitals
Drug diversion can involve high-value non-controlled medications, such as those used to treat cancer or symptoms of opioid use. This week’s featured article provides recommendations for incorporating medications beyond controlled substances in diversion response programs: https://www.ismp.org/node/126033